---
title: "Indivior Pharmaceuticals (INDV.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INDV.US/norm.md"
symbol: "INDV.US"
name: "Indivior Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/INDV.US.md"
datetime: "2026-03-16T22:03:31.987Z"
locales:
  - [en](https://longbridge.com/en/quote/INDV.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INDV.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INDV.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/INDV.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/INDV.US/norm.md)


# Indivior Pharmaceuticals (INDV.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.7898 | 0.3300 | 0.1400 | 0.3790 | 0.1659 |
| ROE | -267.54% | -72.41% | -26.57% | -59.40% | -33.33% |
| Revenue | 358.00M | 314.00M | 302.00M | 266.00M | 299.00M |
| Net income | 102.00M | 42.00M | 18.00M | 47.00M | 21.00M |
| Operating income | 133.00M | 116.00M | 71.00M | 68.00M | 53.00M |
| Gross margin | 84.36% | 85.35% | 82.78% | 83.46% | 83.61% |
| Net margin | 28.49% | 13.38% | 5.96% | 17.67% | 7.02% |
| Profit quality | -60.18% | -297.44% | 44.94% | 90.67% | -311.76% |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.20B | 1.42B | 1.45B | 1.38B | 1.32B |
| Leverage | -12.26 | -6.84 | -5.65 | -4.82 | -3.90 |
| BVPS | -0.7840 | -1.66 | -2.06 | -2.28 | -2.70 |
| Turnover | 0.9845 | 0.8194 | 0.7854 | 0.8274 | 0.7724 |
| Cash & STI | 195.00M | 445.00M | 510.00M | 373.00M | 320.00M |
| Inv & Rec | 153.00M | 155.00M | 149.00M | 163.00M | 167.00M |
| LT assets | 170.00M | 154.00M | 152.00M | 141.00M | 139.00M |
| Net debt | 156.00M | -89.00M | -144.00M | -3.00M | 55.00M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -221.00M | -39.00M | 158.00M | 75.00M | -17.00M |
| Investing CF | -24.00M | -20.00M | -17.00M | -5.00M | 8.00M |
| Financing CF | -5.00M | -3.00M | -5.00M | -17.00M | 40.00M |
| Free CF | 27.13M | -62.50M | 151.38M | 122.50M | -46.88M |
| OCF coverage | -762.07% | -162.50% | 752.38% | 833.33% | -6.69% |
| Repaid & issued | - | - | - | - | 332.00M |
| CapEx | -24.00M | -20.00M | -17.00M | -5.00M | -16.00M |